TCL46-05

The Cancer Letter

Inside information on cancer research and drug development

Vol.
46
No.
5
January 31, 2020Jan 31, 2020
DOWNLOAD THE PDF
Thomas Lynch lists his areas of emphasis at the Hutch: Solid tumors, immuno-oncology, big data, microbial involvement
Cover Story
Conversation with The Cancer LetterFree

Thomas Lynch lists his areas of emphasis at the Hutch:

Solid tumors, immuno-oncology, big data, microbial involvement
By Paul Goldberg
On Feb. 1, Thomas J. Lynch will report to work as president and director of Fred Hutchinson Cancer Research Center.
SU2C initiatives aim to boost diversity in cancer trials
By Alexandria Carolan
Surgeon General's report notes lack of evidence on e-cigarettes in smoking cessation
By Alexandria Carolan

Can you spare 10 minutes to complete a survey?

Your feedback is really important—you're helping us shape our coverage priorities and services to better serve you, our readers.
COMPLETE OUR SURVEY

Login

Site license subscribers:
Log in with your IP | Register a sponsored account